Focused Wealth Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Focused Wealth Management’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-80	Closed	-$2K	–	763
2014 Q3	$2K	Hold	80	–	–	﹤0.01%	626
2014 Q2	$2K	Hold	80	–	–	﹤0.01%	619
2014 Q1	$3K	Sell	80 -9	-10%	-$308	﹤0.01%	548
2013 Q4	$2K	Hold	89	–	–	﹤0.01%	577
2013 Q3	$1K	Buy	+89	New	+$1.03K	﹤0.01%	580

Other funds holding CTIC

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Focused Wealth Management's CTIC Position: Q4 2014 in Review

Focused Wealth Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2014, closing a stake of 80 shares — an estimated $2K sold.

Focused Wealth Management first reported a position in CTIC in Q3 2013 and held it in 5 quarters. The position peaked at $3K in Q1 2014. 90 funds tracked by Wall St. Rank hold CTIC as of Q4 2014.

Focused Wealth Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2014 after selling out during the quarter.
Focused Wealth Management sold 80 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2014, an estimated $2K.
Focused Wealth Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 5 quarters.
Focused Wealth Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $3K in Q1 2014.
90 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2014.

Based on Focused Wealth Management's 13F filing for Q4 2014, filed 6 Feb 2015.